Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
This trial is conducted in Asia, Europe and Oceania. The aim of this trial is to evaluate the efficacy of placebo and activated recombinant human factor VII in patients having undergone allogeneic or autologous stem cell transplantation.
Epistemonikos ID: 58011b5b84277ca6d219c04a0b47631ff1978ca6
First added on: May 10, 2024